We have previously reported our preclinical data on the use of intratumoral injection of CCL21-DC in murine models of established lung cancer resulting in tumor eradication by eliciting a systemic anti-tumor immune response that provided protection against subsequent challenge with the same tumor cell line [27,28]. Here, CCL21 is linked to lung carcinoma.